Episode 92 | Nick Accordino and Will Braeutigam: Deloitte | Taking your Medtech Company Public: SPACs vs. IPOs
May 09, 2022•1 hr 9 min•Season 1Ep. 92
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
- In this episode, Nick Accordino and Will Braeutigam from Deloitte and Duane Mancini discuss discuss SPACs, what are SPACs, why would a company want to go public, the differences in going public through an IPO vs. SPAC, strategic acquisition vs. going public, the myths of going public via a SPAC, preparing your company to go public, and so much more.
- Nick Accordino LinkedIn
- Will Braeutigam LinkedIn
- Deloitte Website
- Project Medtech Website
- Duane Mancini LinkedIn
- Project Medtech LinkedIn
For the best experience, listen in Metacast app for iOS or Android